Intraperitoneal Injection of Bacterial Lipopolysaccharide in Mice to Study Systemic Immune Responses

Key Points

• Systemic inflammation is induced in mice through lipopolysaccharide injection, leading to immune response activation.
• Injected lipopolysaccharide mimics microbial-derived products following intestinal barrier breaches, eliciting physiological changes.
• The method described shows a clear procedure for intraperitoneal injection, emphasizing its significance in immune research.
• Further studies may explore the relationship between gut health and systemic inflammation, noting the model's limitations.